Amrize Financials - Benzinga

Amrize Ltd

AMRZNYSE

Trade with Public

Trade with Public

$37.90

-1.10-2.82%

近くで: Sep 23, 5:00 PM EST

$37.90

N/A

時間外: 4:00 PM EST

概要ニュース業績予想目標株価財務センチメント株主構成比較オプション株式レポート

Amrize Financials

Amrize (AMRZ) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Amrize Raises FY2026 Sales Guidance from $12.290B-$12.520B to $12.500B-$12.700B vs $12.464B Est

Amrize (NYSE:AMRZ) raises FY2026 sales outlook from $12.290 billion-$12.520 billion to $12.500 billion-$12.700 billion vs $12.464 billion estimate.

Benzinga Newsdesk

PRO
Amrize Q2 Adj. EPS $0.88 Misses $0.94 Estimate, Sales $3.494B Beat $3.365B Estimate

Amrize (NYSE:AMRZ) reported quarterly earnings of $0.88 per share which missed the analyst consensus estimate of $0.94 by 6.38 percent. This is a 12.82 percent increase over earnings of $0.78 per share from the same

Benzinga Newsdesk

PRO
Amrize Affirms FY2026 Sales Guidance of $12.290B-$12.520B vs $12.420B Est

Amrize (NYSE:AMRZ) affirms FY2026 sales outlook from $12.290 billion-$12.520 billion to $12.290 billion-$12.520 billion vs $12.420 billion estimate.

Benzinga Newsdesk

PRO
Amrize Q1 Adj. EPS $(0.16) Misses $(0.13) Estimate, Sales $2.178B Beat $2.144B Estimate

Amrize (NYSE:AMRZ) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 14.29 percent decrease over losses of $(0.14) per share from the same

Benzinga Newsdesk

Earnings Scheduled For April 29, 2026

Benzinga Insights

PRO
Amrize Sees FY2026 Sales $12.290B-$12.520B vs $12.418B Est

Amrize (NYSE:AMRZ) sees FY2026 sales of $12.290 billion-$12.520 billion vs $12.418 billion analyst estimate.

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved